The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than a million hospitalizations each year. Continue Reading Category:Illnesses and conditions, Body and Mind Tags:FDA, clinical trials, Drug delivery, Drug development, Fluid, Heart Failure, Heart Disease, Liver disease, kidney
